Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 16Active not recruiting 2Unknown 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 1854Neoplasms 1242Colorectal Neoplasms 1049Carcinoma, Non-Small-Cell Lung 1001Stomach Neoplasms 798Carcinoma, Hepatocellular 781Lung Neoplasms 759Prostatic Neoplasms 690Pancreatic Neoplasms 571Rectal Neoplasms 445Neoplasm Metastasis 404Ovarian Neoplasms 401Colonic Neoplasms 401Uterine Cervical Neoplasms 399Recurrence 382Leukemia, Myeloid, Acute 370Esophageal Neoplasms 355Multiple Myeloma 339Lymphoma 333Head and Neck Neoplasms 328Melanoma 307Precursor Cell Lymphoblastic Leukemia-Lymphoma 289Brain Neoplasms 264Urinary Bladder Neoplasms 250Nasopharyngeal Carcinoma 222Liver Neoplasms 221Leukemia 218Lymphoma, Large B-Cell, Diffuse 215Polycystic Ovary Syndrome 208Squamous Cell Carcinoma of Head and Neck 203

Interventions

Taxes 1Paclitaxel 1Metformin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Endometrial Adenocarcinoma × Clear all
NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

GOG Foundation

Phase 2/3 Unknown
469 enrolled 16 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡